Literature DB >> 11564048

Best practice in therapeutic drug monitoring.

A S Gross1.   

Abstract

It is the goal of Therapeutic Drug Monitoring (TDM) to use drug concentrations to manage a patient's medication regime and optimise outcome. Limited resources require that drug assays should only be performed when they do contribute to patient management. For this to be the case a therapeutic drug monitoring service has a far greater role than just therapeutic drug measuring. This article describes the roles and functions of a Best Practice TDM service. The features which can and should be strived for in each step of the TDM process-the decision to request a drug level, the biological sample, the request, laboratory measurement, communication of results by the laboratory, clinical interpretation and therapeutic management-are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11564048      PMCID: PMC2014621          DOI: 10.1046/j.1365-2125.2001.0520s1005.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  18 in total

1.  Monitoring drug therapy.

Authors:  Thierry Buclin; Verena Gotta; Aline Fuchs; Nicolas Widmer; Jeffrey Aronson
Journal:  Br J Clin Pharmacol       Date:  2012-06       Impact factor: 4.335

Review 2.  Correlations between imatinib pharmacokinetics, pharmacodynamics, adherence, and clinical response in advanced metastatic gastrointestinal stromal tumor (GIST): an emerging role for drug blood level testing?

Authors:  Margaret von Mehren; Nicolas Widmer
Journal:  Cancer Treat Rev       Date:  2010-11-24       Impact factor: 12.111

3.  A 3-year prospective study of a multidisciplinary early proactive therapeutic drug monitoring programme of infliximab treatments in inflammatory bowel disease.

Authors:  José Germán Sánchez-Hernández; Noemí Rebollo; Ana Martin-Suarez; M Victoria Calvo; Fernando Muñoz
Journal:  Br J Clin Pharmacol       Date:  2020-02-21       Impact factor: 4.335

4.  Recommended Approaches for Pharmacokinetic Natural Product-Drug Interaction Research: a NaPDI Center Commentary.

Authors:  Mary F Paine; Danny D Shen; Jeannine S McCune
Journal:  Drug Metab Dispos       Date:  2018-05-07       Impact factor: 3.922

5.  Kinetic nomograms assist individualization of drug regimens.

Authors:  Hafedh Marouani; Anastasios Zografidis; Athanassios Iliadis
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

6.  Therapeutic drug monitoring of antidepressants in haemodialysis patients.

Authors:  Stefan Unterecker; Philip Müller; Christian Jacob; Peter Riederer; Bruno Pfuhlmann
Journal:  Clin Drug Investig       Date:  2012-08-01       Impact factor: 2.859

Review 7.  Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Authors:  Rob E Aarnoutse; Jonathan M Schapiro; Charles A B Boucher; Yechiel A Hekster; David M Burger
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  How to optimize the evaluation and use of antibiotics in neonates.

Authors:  Evelyne Jacqz-Aigrain; Florentia Kaguelidou; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-09-01       Impact factor: 3.278

9.  Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions.

Authors:  S Unterecker; P Riederer; F Proft; J Maloney; J Deckert; B Pfuhlmann
Journal:  J Neural Transm (Vienna)       Date:  2012-12-20       Impact factor: 3.575

Review 10.  Overview of therapeutic drug monitoring.

Authors:  Ju Seop Kang; Min Ho Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.